Table of Content




Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 End Use
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market: Variables, Trends, & Scope
3.1 Segment Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing innovation in testing services
3.2.1.2 Regulation safety and quality
3.2.1.3 Pricing
3.2.2 Market Restraint Analysis
3.2.2.1 Data insecurity
3.2.2.2 Third-party performance
3.3 Penetration & Growth Prospect Mapping
3.4 U.S. Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 PESTEL Analysis
Chapter 4 U.S. Pharmaceutical Analytical Testing Outsourcing Market: Service Segment Analysis
4.1 U.S. Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2019 & 2027
4.2 Bioanalytical Testing
4.2.1 Bioanalytical Testing Market, 2016 - 2027 (USD Million)
4.2.2 Clinical
4.2.2.1 Clinical market, 2016 - 2027 (USD Million)
4.2.3 Non-clinical
4.2.3.1 Non-clinical market, 2016 - 2027 (USD Million)
4.3 Method Development & Validation
4.3.1 Method Development & Validation Market, 2016 - 2027 (USD Million)
4.3.2 Extractable & Leachable
4.3.2.1 Extractable & Leachable market, 2016 - 2027 (USD Million)
4.3.3 Impurity Method
4.3.3.1 Impurity Method market, 2016 - 2027 (USD Million)
4.3.4 Technical Consulting
4.3.4.1 Technical Consulting market, 2016 - 2027 (USD Million)
4.3.5 Others
4.3.5.1 Others market, 2016 - 2027 (USD Million)
4.4 Stability Testing
4.4.1 Stability Testing Market, 2016 - 2027 (USD Million)
4.4.2 Drug Substance
4.4.2.1 Drug Substance market, 2016 - 2027 (USD Million)
4.4.3 Stability Indicating Method Validation
4.4.3.1 Stability Indicating Method Validation market, 2016 - 2027 (USD Million)
4.4.4 Accelerated Stability Testing
4.4.4.1 Accelerated Stability Testing market, 2016 - 2027 (USD Million)
4.4.5 Photostability Testing
4.4.5.1 Photostability Testing market, 2016 - 2027 (USD Million)
4.4.6 Others
4.4.6.1 Others market, 2016 - 2027 (USD Million)
4.5 Other Testing Services
Chapter 5 U.S. Pharmaceutical Analytical Testing Outsourcing Market: End-use Segment Analysis
5.1 U.S. Pharmaceutical Analytical Testing Outsourcing: Market Share Analysis, 2019 & 2027
5.2 Pharmaceutical Companies
5.2.1 Pharmaceutical Companies U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2016 - 2027 (USD Million)
5.3 Biopharmaceutical Companies
5.3.1 Biopharmaceutical Companies U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2016 - 2027 (USD Million)
5.4 Contract Research Organizations
5.4.1 Contract Research Organisations U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2016 - 2027 (USD Million)
Chapter 6 Competitive Analysis
6.1 Competitive Insights
6.2 Major Deals & Strategic Alliances Analysis
6.2.1 Mergers & Acquisitions
6.2.2 Expansions
6.2.3 Collaborations
6.2.4 Product Launch
Chapter 7 Company Profiles
7.1 Company Profiles
7.2 West Pharmaceutical Services, Inc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Service Benchmarking
7.2.4 Strategic Initiatives
7.3 Sgs Sa
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Service Benchmarking
7.3.4 Strategic Initiatives
7.4 Eurofins Scientific
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Service Benchmarking
7.4.4 Strategic Initiatives
7.5 Pace Analytical Services Llc
7.5.1 Company Overview
7.5.2 Service Benchmarking
7.5.3 Strategic Initiatives
7.6 Intertek Group Plc
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Service Benchmarking
7.6.4 Strategic Initiatives
7.7 Pharmaceutical Product Development, LLC.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Service Benchmarking
7.7.4 Strategic Initiatives
7.8 Wuxi Apptec, Inc.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Service Benchmarking
7.8.4 Strategic Initiatives
7.9 Boston Analytical
7.9.1 Company Overview
7.9.2 Service Benchmarking
7.9.3 Strategic Initiatives
7.10 Charles River Laboratories International, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Service Benchmarking
7.10.4 Strategic Initiatives



List of Tables




Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Pharmaceutical Analytical Testing Outsourcing Market, By Service, 2016 - 2027 (USD Million)
Table 4 U.S. Pharmaceutical Analytical Testing Outsourcing Market, By End Use, 2016 - 2027 (USD Million)